1. Home
  2. VNDA vs VMD Comparison

VNDA vs VMD Comparison

Compare VNDA & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • VMD
  • Stock Information
  • Founded
  • VNDA 2002
  • VMD 2006
  • Country
  • VNDA United States
  • VMD United States
  • Employees
  • VNDA N/A
  • VMD N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • VMD
  • Sector
  • VNDA Health Care
  • VMD
  • Exchange
  • VNDA Nasdaq
  • VMD Nasdaq
  • Market Cap
  • VNDA 282.8M
  • VMD 288.1M
  • IPO Year
  • VNDA 2006
  • VMD N/A
  • Fundamental
  • Price
  • VNDA $4.99
  • VMD $7.49
  • Analyst Decision
  • VNDA Strong Buy
  • VMD
  • Analyst Count
  • VNDA 2
  • VMD 0
  • Target Price
  • VNDA $16.50
  • VMD N/A
  • AVG Volume (30 Days)
  • VNDA 673.5K
  • VMD 108.3K
  • Earning Date
  • VNDA 05-07-2025
  • VMD 03-10-2025
  • Dividend Yield
  • VNDA N/A
  • VMD N/A
  • EPS Growth
  • VNDA N/A
  • VMD 12.00
  • EPS
  • VNDA N/A
  • VMD 0.28
  • Revenue
  • VNDA $198,772,000.00
  • VMD $224,257,000.00
  • Revenue This Year
  • VNDA $14.36
  • VMD $13.27
  • Revenue Next Year
  • VNDA $44.53
  • VMD $14.11
  • P/E Ratio
  • VNDA N/A
  • VMD $26.46
  • Revenue Growth
  • VNDA 3.18
  • VMD 22.54
  • 52 Week Low
  • VNDA $3.71
  • VMD $6.21
  • 52 Week High
  • VNDA $6.75
  • VMD $9.81
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 57.32
  • VMD 41.63
  • Support Level
  • VNDA $4.84
  • VMD $7.33
  • Resistance Level
  • VNDA $5.16
  • VMD $7.87
  • Average True Range (ATR)
  • VNDA 0.23
  • VMD 0.25
  • MACD
  • VNDA 0.02
  • VMD -0.00
  • Stochastic Oscillator
  • VNDA 66.10
  • VMD 26.15

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

Share on Social Networks: